| Visualizaciones | |
|---|---|
| Preparation and in vitro evaluation of 177Lu-iPSMA-RGD as a new heterobivalent radiopharmaceutical | 401 |
| julio 2024 | agosto 2024 | septiembre 2024 | octubre 2024 | noviembre 2024 | diciembre 2024 | enero 2025 | |
|---|---|---|---|---|---|---|---|
| Preparation and in vitro evaluation of 177Lu-iPSMA-RGD as a new heterobivalent radiopharmaceutical | 3 | 1 | 3 | 0 | 2 | 4 | 12 |
| Visualizaciones | |
|---|---|
| 34-2017 Journal of Radioanalytical and Nuclear Chemistry-Alondra-1.pdf | 390 |
| Visualizaciones | |
|---|---|
| Estados Unidos | 157 |
| México | 56 |
| Alemania | 51 |
| China | 19 |
| Canadá | 16 |
| Rusia | 11 |
| Austria | 10 |
| Ucrania | 9 |
| India | 3 |
| Suecia | 3 |
| Visualizaciones | |
|---|---|
| Kiez | 49 |
| Woodbridge | 24 |
| Fairfield | 19 |
| Houston | 14 |
| Cambridge | 12 |
| Ottawa | 12 |
| Dearborn | 11 |
| Jacksonville | 11 |
| Mexico | 10 |
| Vienna | 10 |